Your browser doesn't support javascript.
loading
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
Milgrom, Sarah A; Pinnix, Chelsea C; Chuang, Hubert; Oki, Yasuhiro; Akhtari, Mani; Mawlawi, Osama; Garg, Naveen; Gunther, Jillian R; Reddy, Jay P; Smith, Grace L; Rohren, Eric; Hagemeister, Frederick B; Lee, Hun J; Fayad, Luis E; Dong, Wenli; Osborne, Eleanor M; Abou Yehia, Zeinab; Fanale, Michelle; Dabaja, Bouthaina S.
  • Milgrom SA; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Pinnix CC; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Chuang H; Department of Nuclear Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Oki Y; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Akhtari M; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Mawlawi O; Department of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA.
  • Garg N; Department of Diagnostic Radiology, MD Anderson Cancer Center, Houston, TX, USA.
  • Gunther JR; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Reddy JP; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Smith GL; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Rohren E; Department of Radiology, Baylor College of Medicine, Houston, TX, USA.
  • Hagemeister FB; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Lee HJ; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Fayad LE; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Dong W; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
  • Osborne EM; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Abou Yehia Z; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Fanale M; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Dabaja BS; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 179(3): 488-496, 2017 11.
Article en En | MEDLINE | ID: mdl-28832956
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article